Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open-label study

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case SeriesCohort Study · 2014 · 82 citations
2. 2Sustained response and prevention of damage progression in patients with neonatal‐onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three‐ and five‐year outcomesCohort Study · 2012 · 221 citations
3. 3Behcet's disease: evaluation of a new instrument to measure clinical activityOriginal Research · 1999 · 321 citations
4. 4Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled StudyRCT · 2015 · 245 citations
5. 5A Controlled Trial of Azathioprine in Behçet's SyndromeRCT · 1990 · 647 citations